ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

10809	Companies
234058	Keywords
162793	Articles
125042	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 07/02/2026 at 08:00, 1 month 4 days ago

Abivax annonce l’exercice intégral de l’option de souscription d’ADS supplémentaires des teneurs de livre associés, portant le produit brut de l’Offre à 920 M$ (807 M€)
Abivax annonce l'exercice intégral de l'option de souscription d'ADS supplémentaires, atteignant un produit brut de 920 M$ (807 M€). Utilisation prévue pour financer commercialisation, R&D et besoins généraux

Biotechnologie Abivax Rectocolite Hémorragique Produit Brut Option De Souscription
PRESS RELEASE

published on 07/02/2026 at 08:00, 1 month 4 days ago

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
Abivax announces full exercise of underwriters' option to purchase additional ADSs, bringing gross proceeds of offering to $920M (€807M)

Biotechnology Abivax Capital Increase Underwriters ADSs
BRIEF

published on 07/01/2026 at 15:17, 1 month 5 days ago

Abivax resumes trading of its shares on Euronext Paris

Euronext Paris Biotechnology Actions Abivax Suspension
BRIEF

published on 07/01/2026 at 15:17, 1 month 5 days ago

Abivax reprend la cotation de ses actions sur Euronext Paris

Euronext Paris Biotechnologie Actions Abivax Suspension
BRIEF

published on 07/01/2026 at 15:17, 1 month 5 days ago

Abivax relance la cotation de ses actions sur Euronext Paris

Euronext Paris Abivax Actions Ordinaires Maladies Inflammatoires American Depositary Shares
BRIEF

published on 07/01/2026 at 15:17, 1 month 5 days ago

Abivax relaunches trading of its shares on Euronext Paris

Euronext Paris Ordinary Shares Abivax Inflammatory Diseases American Depositary Shares
PRESS RELEASE

published on 07/01/2026 at 15:12, 1 month 5 days ago

Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris. La société de biotechnologie se concentre sur le développement de traitements pour les maladies inflammatoires chroniques

Euronext Paris Biotechnologie Abivax Maladies Inflammatoires Traitements
PRESS RELEASE

published on 07/01/2026 at 15:12, 1 month 5 days ago

Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris. Abivax SA, société de biotechnologie au stade clinique, développe des traitements pour stabiliser la réponse immunitaire chez les patients

Euronext Paris Biotechnologie Abivax Actions Ordinaires Reprise Des Négociations
BRIEF

published on 07/01/2026 at 14:59, 1 month 5 days ago

Abivax Resumes Trading on Euronext Paris

Euronext Paris Biotechnology Abivax Ulcerative Colitis American Depositary Shares
BRIEF

published on 07/01/2026 at 14:59, 1 month 5 days ago

Abivax reprend sa cotation sur Euronext Paris

Euronext Paris Biotechnologie Abivax Rectocolite Hémorragique Actions De Dépôt Américaines

Accesswire

Published on 08/06/2026 at 15:00, 1 hour 32 minutes ago

Norsemont Strategically Expands Choquelimpie Land Package To 9,048 Hectares
Published on 08/06/2026 at 14:30, 2 hours 2 minutes ago

Loar Holdings Inc. Reports Q2 2026 Record Results and Upward Revision to 2026 Outlook
Published on 08/06/2026 at 14:30, 2 hours 2 minutes ago

NV Gold Announces Expansion of Holdings and Drill Program at the Slumber Gold Project in Nevada
Published on 08/06/2026 at 14:30, 2 hours 2 minutes ago

AIAI Holdings' MediGuide Launches Longevity Intelligence, Redefining Personalized Preventive Healthcare
Published on 08/06/2026 at 14:00, 2 hours 32 minutes ago

Adcore to Publish Second Quarter 2026 Results on August 13, 2026

View all ACCESSWIRE

EQS Group

Published on 08/06/2026 at 16:15, 17 minutes ago

Monotype and Kittl Expand Partnership To Bring Brand Typography Directly Into Creative Workflows
Published on 08/06/2026 at 15:20, 1 hour 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Published on 08/06/2026 at 15:19, 1 hour 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 08/06/2026 at 15:19, 1 hour 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 08/06/2026 at 15:18, 1 hour 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited

Les Echos

Published on 08/06/2026 at 08:44, 7 hours 47 minutes ago

IDI annonce la cession du groupe Talis à son fondateur, Serge Marcillaud, accompagné de l'équipe dirigeante
Published on 08/06/2026 at 08:00, 8 hours 32 minutes ago

EURAZEO ENTRE EN DISCUSSIONS EXCLUSIVES AVEC PARTNERS GROUP EN VUE DE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET DE SON RÉINVESTISSEMENT À SES CÔTÉS
Published on 08/06/2026 at 08:00, 8 hours 32 minutes ago

EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Published on 08/06/2026 at 07:48, 8 hours 43 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 juillet 2026
Published on 08/05/2026 at 18:00, 22 hours 32 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026

View all LES ECHOS COMFI WIRE